Phytochemistry, traditional uses and cancer chemopreventive activity of Amla (Phyllanthus emblica): The Sustainer

Journal of Applied Pharmaceutical Science

Volumn 2, Issue 1, 2012, Pages 176-183

  Singh, Ekta ^a   Sharma, Sheel ^a   Pareek, Ashutosh ^a   Dwivedi, Jaya ^a   Yadav, Sachdev ^a   Sharma, Swapnil ^a  

^a BANASTHALI UNIVERSITY   (India)

Author keywords

Anticarcinogenic; Antitumor activity; Medicinal herb; Phyllanthus emblica

Indexed keywords

EID: 84871414677     PISSN: None     EISSN: 22313354     Source Type: Journal    
DOI: None     Document Type: Article

References (65)

1. Anila L, Vijayalakshmi NR. Flavonoids from Emblica officinalis and Mangifera indica -effectiveness for dyslipidemia. J Ethnopharmacol. 2002; 79(1):81-87.
2. Arora S, Kaur K, Kaur S. Indian medicinal plants as a reservoir of protective phytochemicals. Teratog Carcinog Mutagen. 2003; (suppl 1):295-300.
3. Akhtar MS, Ramzan A, Ali A, Ahmad M. Effect of Amla fruit (Emblica officinalis Gaertn.) on blood glucose and lipid profile of normal subjects and type 2 diabetic patients. Int J Food Sci Nutr. 2011 Apr 18. [Epub ahead of print]
4. Bajpai M, Pande A, Tewari SK, Prakash D. Phenolic contents and antioxidant activity of some food and medicinal plants. Int J Food Sci Nutr. 2005; 56(4):287-291.
5. Bhattacharya SK, Bhattacharya A, Sairam K, Ghosal S. Effect of bioactive tannoid principles of Emblica officinalis on ischemia-reperfusion-induced oxidative stress in rat heart. Phytomedicine. 2002; 9(2):171-174.
6. Bandyopadhyay SK, Pakrashi SC, Pakrashi A. The role of antioxidant activity of Phyllanthus emblica fruits on prevention from indomethacin induced gastric ulcer. J Ethnopharmacol. 2000; 70(2):171-176.
7. Brun V, Schumacher T. Traditional Herbal Medicine in Northern Thailand. University of California Press, Berkeley, 1987; 349.
8. Banu SM, Selvendiran K, Singh JP, Sakthisekaran D. Protective effect of Emblica officinalis ethanolic extract against 7,12-dimethylbenz(a) anthracene (DMBA) inducedgenotoxicity in Swiss albino mice. Hum Exp Toxicol .2004; 23: 527-31.
9. Bajracharya, M. B. Ayurvedic Medicinal Plants. Kathmandu; Piyusavarsi Ausadhalaya, 1979
10. Bharthakur NN, Arnold NP. Chemical analysis of the emblic (Phyllanthus emblica L) and its potential as a good sources. Scientia Horticult 1991; 47:99-105.
11. Babu PS, Stanely Mainzen Prince P. Antihyperglycaemic and antioxidant effect of hyponidd, an ayurvedic herbomineral formulation in streptozotocin-induced diabetic rats. J Pharm Pharmacol 2004; 56(11):1435-1442.
12. Biswas NR, Gupta SK, Das GK, et al.,, Evaluation of Ophthacare eye drops - a herbal formulation in the management of various ophthalmic disorders. Phytother Res. 2001; 15(7):618-620.
13. Bhattacharya A, Chatterjee A, Ghosal S, Bhattacharya SK. Antioxidant activity of active tannoid principles of Emblica officinalis (amla). Indian J Exp Biol 1999 Jul; 37(7):676-80.
14. Bunyapraphatsara N. Personal communication: uses of Phyllanthus species in traditional Thai medicine, translated from nine books in Thai. Medicinal Plant Information Center,.Mahidol University, Bangkok, 1987.
15. Burkill, I. H. A Dictionary of the Economic Products of the Malay Peninsula, Vol. 1, Ministry of Agriculture and Co-operatives, Kuala Lump 1966.
16. Chaudhuri, Ratan K. Standardised extract of Phyllanthus emblica: A skin lightener with anti-aging benefits. Proceedings PCIA Conference, Guangzhou, China 9-11 March 2004.
17. Chaudhuri, Ratan K. Guttierez, Gilles and Serrar, Mustafa: Low Molecular-Weight Tannins of Phyllanthus emblica: A New Class of Anti-Aging Ingredients. Proceedings Active Ingredients Conference, Paris. 2003.
18. Chen TS, Liou SY, Chang YL. Supplementation of Emblica officinalis (Amla) extract reduces oxidative stress in uremic patients. Am J Chin Med. 2009; 37(1):19-25.
19. Dragendorff, G., Die Heilpflunzen der Verschiedenen Viilker und Zeiten. Verlag von Ferdinand Enke, Stuttgart, (1898) 373-374.
20. Dang GK, Parekar RR, Kamat SK, Scindia AM, Rege NN. Antiinflammatory activity of Phyllanthus emblica, Plumbago zeylanica and Cyperus rotundus in acute models of inflammation. Phytother Res. 2011; 25(6):904-908.
21. Dutta BK, Rahman I, Das TK. Antifungal activity of Indian plant extracts. Mycoses. 1998; 41(11-12):535-536.
22. Drury, Colonel Heber: The useful plants of India; with notices of their chief medicinal value in commerce, medicine and the arts. Higginbotham and Co. Madras. 1873.
23. El-Desouky SK, Ryu SY, Kim YK. A new cytotoxic acylated apigenin glucoside from Phyllanthus emblica L. Nat Prod Res 2008; 22: 91-95.
24. Garima Sancheti, Archana Jindal, Rimpu Kumari, Goyal. Chemopreventive Action of Emblica Officinalis on Skin Carcinogenesis in mice. Asian Pacific J Cancer Prev 2005; 6: 197-201.
25. Ghosal S, Tripathi VK, Chauhan S. Active constituent of Emblicaofficinalis: part 1st the chemistry and antioxidant effects of two new hydrolysable tannins, emblicanin A and B. Indian J Chem.1996; 35b: 941-948.
26. Gopalan C, Sastri BVR, Balasubramaniam SC. Nutritive value of Indian foods. NIN, Hyderabad, India, 1991
27. His Majesty's Government of Nepal, Ministry of Forest and SoilConservation, Department of Medicinal Plants. Medicinal Plants of Nepal (3rd Ed). His Majesty's Government Press, Kathmandu, 1982, pp. 185.
28. Jain SK, akhurdiya DS. Anola: Potential fruit for processing Delhi Garden Mega 2000; 38:50-51.
29. Jayaweera, D.M.A.: Medicinal Plants used in Ceylon Part 2. National Science Council of Sri Lanka. Colombo 1980.
30. Jacob A, Pandey M, Kapoor S, Saroja R. Effect of the Indian gooseberry (amla) on serum cholesterol levels in men aged 35-55 years. Eur J Clin Nutr. 1988; 42(11):939-944.
31. Jeena KJ, Kuttan G, George J, Kuttan R. Antimutagenic and anticarcinogenic activity of Emblica officinalis Gaertn. J Clin Biochem Nutr 1996; 22: 171-176.
32. Jose JK, Kuttan G, Kuttan R. Antitumour activity of Emblica officinalis. J Ethnopharmacol 2001; 75: 65-69.
33. Kim HJ, Yokozawat, Kimhy, Tohda C, Rao TP, JunejaLR. Influence of Amla (Emblica Officinalis Gaertnl) on hypercholesterolemia and lipid peroxidation in cholesterol-fed rats. J Nutr Sci Vitaminol 2005; 51:413-418.
34. Kapoor LD. Handbook of Ayurvedic Medicinal Plants. CRC Press. Boca taton 1990.
35. Rastogi RP, Mehrotra BN. Compendium of Indian Plants. CDRI, Lucknow and Publications & Information Directorate, New Delhi, 1993.
36. Kumaran A, Karunakaran RJ. Nitric oxide radical scavenging active components from Phyllanthus emblica L. Plant Foods Hum Nutr 2006; 61(1):1-5.
37. Mathur R, Sharma A, Dixit VP, Varma M. Hypolipidaemic effect of fruit juice of Emblica officinalis in cholesterol-fed rabbits. J Ethnopharmacol. 1996; 50(2):61-68.
38. Mehmood MH, Siddiqi HS, Gilani AH. The antidiarrheal and spasmolytic activities of Phyllanthus emblica are mediated through dual blockade of muscarinic receptors and Ca2+ channels. J Ethnopharmaco. 2011; 133(2):856-865.
39. Muthuraman A, Sood S, Singla SK. The antiinflammatory potential of phenolic compounds from Emblica officinalis L. in rat. Inflammopharmacology. 2010 Jul 2. [Epub ahead of print]
40. Madhavi D, Rudrama Devi K, Kesava Rao K, Reddy PP. Modulating effect of Phyllanthus fruit extract against lead genotoxicity in germ cells of mice. J Envi Biol 2007; 28: 115-117.
41. Nandi P, Talukder G, Sharma A. Dietary chemoprevention of clastogenic effects of 3, 4-benzo (a)pyrene by Emblica officinalis Gaertn. fruit extract. Br J Cancer 1997; 76: 1279-1283.
42. Nadkarni, K.M., Nadkarni, A.K. Indian Materia Medica - with Ayurvedic, Unani-Tibbi, Siddha, Allopathic, Homeopathic, Naturopathic and Home remedies. Popular Prakashan Private Ltd., Bombay, India. 1999; 1(81):7154-142-9.
43. Nampoothiri SV, Prathapan A, Cherian OL, Raghu KG, Venugopalan VV, Sundaresan A. In vitro antioxidant and inhibitory potential of Terminalia bellerica and Emblica officinalis fruits against LDL oxidation and key enzymes linked to type 2 diabetes. Food Chem Toxicol. 2011; 49(1):125-131.
44. Nisha P, Singhal RS, Pandit AB. A study on degradation kinetics of ascorbic acid in amla (Phyllanthus emblica L.) during cooking. Int J Food Sci Nutr. 2004; 55(5):415-422.
45. Naik GH, Priyadarsini KI, Bhagirathi RG, et al.,, In vitro antioxidant studies and free radical reactions of triphala, an ayurvedic formulation and its constituents. Phytother Res. 2005; 19(7):582-586.
46. Naik GH, Priyadarsini KI, Mohan H. Evaluating the antioxidant activity of different plant extracts and herbal formulations. Res Chem Intermed 2005; 31(1-3):145-151.
47. Nicolis E, Lampronti I, Dechecchi MC, et al.,, Pyrogallol, an active compound from the medicinal plant Emblica officinalis, regulates expression of pro-inflammatory genes in bronchial epithelial cells. Int Immunopharmacol. 2008; 8(12):1672-1680.
48. Onions, Alan: Siddha Medicinal Herbs as Cosmetics Ingredients. SPC, March 1994.
49. Perry, L.M. (1980): Medicinal Plants of East and Southeast Asia: Attributed Properties and Uses, pp. 149-150. MIT Press, Cambridge.
50. Poltanov EA, Shikov AN, Dorman HJ, et al.,, Chemical and antioxidant evaluation of Indian gooseberry (Emblica officinalis Gaertn., syn. Phyllanthus emblica L.) supplements. Phytother Res. 2009; 23(9):1309-1315.
51. Rao TP, Sakaguchi N, Juneja LR, Wada E, Yokozawa T. Amla (Emblica officinalis Gaertn.) extracts reduce oxidative stress in streptozotocin-induced diabetic rats. J Med Food. 2005; 8(3):362-368.
52. Rajeshkumar NV, Radahakrishna Pillai M, Kuttan R. Inductionof Apoptosis in Mouse and Human Carcinoma Cell Lines by Emblica officinalis Polyphenols and its Effect on Chemical Carcinogenesis. J Exp Clin Cancer Res 2003; 22: 201-212.
53. Reddy VD, Padmavathi P, Kavitha G, Gopi S, Varadacharyulu N. Emblica officinalis ameliorates alcohol-induced brain mitochondrial dysfunction in rats. J Med Food. 2011; 14(1-2):62-68.
54. Sabu MC, Kuttan R. Anti-diabetic activity of medicinal plants and its relationship with their antioxidant property. J Ethnopharmacol. 2002; 81(2):155-160.
55. Suryanarayana P, Saraswat M, Petrash JM, Reddy GB. Emblica officinalis and its enriched tannoids delay streptozotocin-induced diabetic cataract in rats. Mol Vis. 2007;13:1291-1297
56. Scartezzini P, Speroni E. Review on some plants of Indian traditional medicine with antioxidant activity. J Ethnopharmacol. 2000; 71(1-2):23-43.
57. Shanmugasundaram KR, Seethapathy PG, Shanmugasundaram ER. Anna Pavala Sindhooram-an antiatherosclerotic Indian drug. J Ethnopharmacol. 1983; 7(3):247-265.
58. Sidhu S, Pandhi P, Malhotra S, Vaiphei K, Khanduja KL. Beneficial effects of Emblica officinalis in L-arginine-induced acute pancreatitis in rats. J Med Food. 2011; 14(1-2):147-155.
59. Sumitra M, Manikandan P, Gayathri VS, Mahendran P, Suguna L. Emblica officinalis exerts wound healing action through up-regulation of collagen and extracellular signal-regulated kinases (ERK1/2). Wound Repair Regen. 2009; 17(1):99-107.
60. Singh MP, Malla SB, Rajbhandari SB, Manandhar A. Medicinal plants of Nepal- retrospects and prospects. Economic Botany1979; 33: 185-198.
61. Stuart GA. Chinese Materia Medica Vegetable Kingdom. American Presbyterian Mission Press, Shanghai, (1911) 558.
62. Sarwat Sultana, Salahuddin Ahmed and Tamanna Jahangir., Emblica officinalis and hepatocarcinogenesis: A chemopreventive study in Wistar rats. J Ethnopharmacol 2008; 118: 1-6.
63. Tasduq SA, Kaisar P, Gupta DK, et al.,, Protective effect of a 50% hydroalcoholic fruit extract of Emblica officinalis against anti-tuberculosis drugs induced liver toxicity. Phytother Res. 2005; 19(3):193-197.
64. Tasduq SA, Mondhe DM, Gupta DK, Baleshwar M, Johri RK. Reversal of fibrogenic events in liver by Emblica officinalis (fruit), an Indian natural drug. Biol Pharm Bull. 2005; 28(7):1304-1306.
65. Thakur, R.S.; Puri, H.S.; Husain, Akhtar: Major Medicinal Plants of India. 1989. Central Institute of Medicinal and Aromatic Plants, Lucknow, India.